Data and implication based comparison of two chronic myeloid leukemia models

  • Received: 01 October 2012 Accepted: 29 June 2018 Published: 01 August 2013
  • MSC : Primary: 34K20, 92C50; Secondary: 92D25.

  • Chronic myeloid leukemia, a disorder of hematopoietic stem cells, is currently treated using targeted molecular therapy with imatinib. We compare two models that describe the treatment of CML, a multi-scale model (Model 1) and a simple cell competition model (Model 2).Both models describe the competition of leukemic and normal cells, however Model 1 also describes the dynamics of BCR-ABL, the oncogene targeted by imatinib, at the sub-cellular level. Using clinical data, we analyze the differences in estimated parameters between the models and the capacity for each model to predict drug resistance. We found that while both models fit the data well, Model 1 is more biologically relevant. The estimated parameter ranges for Model 2 are unrealistic, whereas the parameter ranges for Model 1 are close to values found in literature. We also found that Model 1 predicts long-term drug resistance from patient data, which is exhibited by both an increase in the proportion of leukemic cells as well as an increase in BCR-ABL/ABL%. Model 2, however, is not able to predict resistance and accurately model the clinical data. These results suggest that including sub-cellular mechanisms in a mathematical model of CML can increase the accuracy of parameter estimation and may help to predict long-term drug resistance.

    Citation: R. A. Everett, Y. Zhao, K. B. Flores, Yang Kuang. Data and implication based comparison of two chronic myeloid leukemia models[J]. Mathematical Biosciences and Engineering, 2013, 10(5&6): 1501-1518. doi: 10.3934/mbe.2013.10.1501

    Related Papers:

  • Chronic myeloid leukemia, a disorder of hematopoietic stem cells, is currently treated using targeted molecular therapy with imatinib. We compare two models that describe the treatment of CML, a multi-scale model (Model 1) and a simple cell competition model (Model 2).Both models describe the competition of leukemic and normal cells, however Model 1 also describes the dynamics of BCR-ABL, the oncogene targeted by imatinib, at the sub-cellular level. Using clinical data, we analyze the differences in estimated parameters between the models and the capacity for each model to predict drug resistance. We found that while both models fit the data well, Model 1 is more biologically relevant. The estimated parameter ranges for Model 2 are unrealistic, whereas the parameter ranges for Model 1 are close to values found in literature. We also found that Model 1 predicts long-term drug resistance from patient data, which is exhibited by both an increase in the proportion of leukemic cells as well as an increase in BCR-ABL/ABL%. Model 2, however, is not able to predict resistance and accurately model the clinical data. These results suggest that including sub-cellular mechanisms in a mathematical model of CML can increase the accuracy of parameter estimation and may help to predict long-term drug resistance.


    加载中
    [1] British Journal of Cancer, 95 (2006), 1136-1141.
    [2] BLOOD, 102 (2003), 414A.
    [3] The New England Journal of Medicine, 340 (1999), 1330-1340.
    [4] PLoS Computational Biology, 5 (2009), 1-11.
    [5] American Journal of Health-System Pharmacy, 63 (2006), S10-S14.
    [6] Science, 293 (2001), 876-880.
    [7] Molecular and Cellular Biology, 26 (2006), 6082-6093.
    [8] PLoS ONE, 6 (2011), e22110.
    [9] Journal of Biological Dynamics, 4 (2010), 315-327.
    [10] PLoS ONE, 2 (2007), e990.
    [11] Biritish Journal of Cancer, 96 (2007), 697-680.
    [12] TRENDS in Pharmacological Sciences, 28 (2007), 197-199.
    [13] Nature, 435 (2005), 1267-1270.
    [14] Leukemia, 17 (2003), 2392-2400.
    [15] Blood Cancer Journal, 1 (2011), e48.
    [16] AIP Advances, 2 (2012), 011002.
    [17] Nature Medicine, 12 (2006), 1181-1184.
    [18] Clinical Cancer Research, 17 (2011), 6812-6821.
  • Reader Comments
  • © 2013 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(1386) PDF downloads(444) Cited by(5)

Article outline

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog